Showing results (31-40 of 109) with videos related to
Sort By:
Pageof 11
The Journal of Experimental Medicine|January 1, 1989
Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemiaD J Peace, M A CheeverCancer Research|June 30, 2001
Identification of T helper epitopes from prostatic acid phosphataseD G McNeel, L D Nguyen, M L DisisLeukemia|July 2, 2003
WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapiesC Rosenfeld, M A Cheever, A GaigerCancer Research|July 1, 1981
Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitroM A Cheever, P D Greenberg, A FeferJournal of the National Cancer Institute|July 1, 1981
Chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: effect of culture duration on therapeutic efficacyM A Cheever, P D Greenberg, A FeferJournal of Biological Response Modifiers|January 1, 1984
Potential for specific cancer therapy with immune T lymphocytesM A Cheever, P D Greenberg, A FeferJournal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Adoptively transferred antigen-specific T cells can be grown and maintained in large numbers in vivo for extended periods of time by intermittent restimulation with specific antigen plus IL-2W Chen, V A Reese, M A CheeverJournal of Mammary Gland Biology and Neoplasia|March 8, 2000
Immunotherapeutic approaches for the treatment of breast cancerK L Knutson, K Schiffman, K Rinn, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1980
Therapy of leukemia by nonimmune syngeneic spleen cellsM A Cheever, P D Greenberg, A FeferThe Journal of Experimental Medicine|September 1, 1981
Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytesP D Greenberg, M A Cheever, A FeferPageof 11